Real-time RT-PCR and western blotting documented significantly elevated RUNX2 expression at days 7 and 14 in both the OM with TGFβ1 and OM with TGFβ2 groups compared with those from BMSCs maintained in OM alone (Figures 5C–F). The gene discussed is TGFB2; the disease is ocular melanoma.